Log in using OpenID

Interventional Neurology Market To Grow Like Never Before By 2026

According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths each year. BAF estimates that aneurysm is predominant in the age group of 35–60 years.
Interventional Neurology Market Progresses for
Huge Profits by 2026
Global Interventional Neurology Market by Product Type (Embolic coils, Carotid
stents, Intracranial stents), by Technique (Neurothrombectomy Procedure,
Cerebral Angiography Technique, Stenting Technique), by Therapeutic
Application (Brain Aneurysm, Ischemic Strokes, Artery Stenosis), by End User
(Hospitals, and Ambulatory Centers), and by Geography - Trends and Forecast
to 2024
According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000
deaths each year. BAF estimates that aneurysm is predominant in the age group of 35–60 years.
Moreover, globally around 15 million people suffer a stroke every year, as per stats released by the
World Heart Federation. High incidence of stroke and brain aneurysm is contributing to increasing
demand for interventional neurology devices. Furthermore, introduction of new techniques such as
flow diverter and aspiration are propelling demand for interventional neurology devices. The global
Interventional neurology market was valued at US$ 1,694.5 million in 2015 and is expected to expand
at a CAGR of 5.3% during the forecast period (2016 – 2024). Click To Read More On Interventional
Neurology Market.
Neurovascular conditions such as stroke and aneurysms are generally treated with tissue plasminogen
activators (tPAs). However, use of neurointerventional devices along with the medication therapy is
more effective in removing clots and reducing the risk of early recurrence of the condition.
Interventional neurology technology has been evolving rapidly, which is resulting in demand shift from
clipping to coiling, coated to bare platinum coils, and so on.
Market dynamics
Factors such as increasing prevalence of brain aneurysms, and stroke, government programs to
decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and
availability of reimbursement are driving demand for neurointerventional devices. However, high cost
and negative perception about neurointerventional devices is impacting the demand negatively.
Companies are therefore, adopting different strategies such as providing FDA approved on-site
training, strategic collaborations, and technology upgrades in order to increase their market presence
and engage with customers.
Ask For Sample Copy Of This Business Research Report :
Innovative neurointerventional devices to cannibalize conventional neurointerventional devices
Coiling is the conventional and more of a gold standard treatment technique for stroke. Increasing
complexities in treating patients suffering from recurring stroke incidents is driving demand for
advanced technological products. Neurointerventional devices such as Intrasaccular devices, stent
retrievers, and flow diverters are expected to gain major traction during the forecast period (2016 –
2024). Intrasaccular devices are expected to be launched in the U.S. and Japan market by 2018.
Realizing the benefits of stent retrievers, the American Heart Association and American Stroke
Association have issued guidelines, recommending the use of stent retrievers along with tPA for
treatment of stroke.
Strategic channel distribution agreements among manufacturers to bolster their regional reach
Codman Neuro entered into agreement with InNeuroCo, Inc. for the European distribution rights for
intermediate catheters (ICs). Similarly, Covidien (now Medtronic) entered into an exclusive
distribution agreement with Pulsar Vascular, Inc. to market and promote PulseRider in Europe, the
Middle East, and Africa. PulseRider is a minimally invasive device intended for use (with embolic
coils) for treatment of unruptured wide-neck intracranial aneurysms. Such strategic distribution
partnership are helping market leaders to expand their global footprint.
Penumbra 3D Revascularization Device (next-generation stroke-treatment device) proved more
effective with Penumbra aspiration device according to the studies conducted by Penumbra, Inc. as
compared to using the aspiration device alone.
Market players need to address demand-shift in devices and procedural techniques
The global Interventional neurology market is undergoing a demand-shift in terms of products and
techniques to treat stroke and aneurysms. For instance, demand for bare platinum coils is growing at a
rapid pace as compared to that for coated coils. This is mainly due to high costs of coated coils and
their less improved clinical outcomes compared to bare platinum coils. The highly touted International
Subarachnoid Aneurysm Trial (ISAT) demonstrated improved clinical outcomes with coils rather than
clipping, which resulted in decline in the usage of clips in neurovascular surgery.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
ravikiran303   documents Email
Health and Medicine
File Size
365 KB
Report inappropriate content